BERZERO, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 1.390
NA - Nord America 968
EU - Europa 661
SA - Sud America 535
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 3.589
Nazione #
US - Stati Uniti d'America 908
CN - Cina 538
BR - Brasile 446
SG - Singapore 443
SE - Svezia 222
HK - Hong Kong 167
VN - Vietnam 143
IT - Italia 104
DE - Germania 92
RU - Federazione Russa 62
AR - Argentina 47
GB - Regno Unito 31
CA - Canada 30
MX - Messico 25
AT - Austria 24
FI - Finlandia 21
ID - Indonesia 19
IE - Irlanda 17
IN - India 17
FR - Francia 16
NL - Olanda 13
PL - Polonia 13
EC - Ecuador 12
ES - Italia 12
JP - Giappone 12
ZA - Sudafrica 12
CO - Colombia 10
LT - Lituania 10
BD - Bangladesh 9
UA - Ucraina 9
IQ - Iraq 6
MA - Marocco 6
PY - Paraguay 6
TR - Turchia 6
A1 - Anonimo 5
AE - Emirati Arabi Uniti 5
CL - Cile 5
KE - Kenya 5
PK - Pakistan 5
UY - Uruguay 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
LB - Libano 3
PH - Filippine 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
RS - Serbia 2
TW - Taiwan 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 3.589
Città #
Singapore 212
Hong Kong 167
New York 161
Shanghai 150
Dallas 145
Ashburn 109
Hefei 77
Lawrence 62
Princeton 62
Ho Chi Minh City 54
Beijing 45
São Paulo 45
Los Angeles 35
Hanoi 33
Nuremberg 30
Guangzhou 21
Munich 21
Orem 18
Dublin 17
Helsinki 16
Milan 16
Belo Horizonte 15
Curitiba 15
Naples 14
Moscow 13
Stockholm 13
Warsaw 13
Montreal 12
Shenzhen 12
Tokyo 11
Vienna 11
Brooklyn 10
Guarulhos 10
Porto Alegre 10
Rio de Janeiro 10
Denver 9
Falkenstein 9
Rome 9
Amsterdam 8
Johannesburg 8
Mexico City 8
Poplar 8
Toronto 8
Boardman 7
Chennai 7
Hangzhou 7
Manchester 7
Phoenix 7
Wuxi 7
Chicago 6
Jiaxing 6
Paris 6
Querétaro 6
San Francisco 6
Ankara 5
Brasília 5
Houston 5
Joinville 5
London 5
Nairobi 5
Salvador 5
Santa Clara 5
Seattle 5
Atlanta 4
Baghdad 4
Belém 4
Berlin 4
Bolzano 4
Buenos Aires 4
Catanduva 4
Cuiabá 4
Foshan 4
Frankfurt am Main 4
Guayaquil 4
Hortolândia 4
Hải Dương 4
Manassas 4
Montevideo 4
Quanzhou 4
Uberlândia 4
Vancouver 4
Volta Redonda 4
Agadir 3
Bari 3
Bologna 3
Bắc Giang 3
Cabanatuan City 3
Cape Town 3
Caruaru 3
Duque de Caxias 3
Ha Long 3
Haiphong 3
Huzhou 3
Ipatinga 3
Jundiaí 3
La Plata 3
Lappeenranta 3
Lấp Vò 3
Maceió 3
Manaus 3
Totale 1.979
Nome #
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 87
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 83
Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity 75
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 74
Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients 74
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors 72
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder 71
CAR-T Cells for the Treatment of Central Nervous System Tumours: Known and Emerging Neurotoxicities 71
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies 68
Brain metastases from lung cancer: Is MET an actionable target? 68
Current therapeutic approaches to diffuse grade II and III gliomas 67
CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies 66
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 66
Cranial nerve palsies in patients with hematological malignancies: a case series 65
Acute late-onset encephalopathy after radiotherapy: An unusual life-threatening complication 65
Liquid biopsy in brain tumors: moving on, slowly 64
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 63
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient 63
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study 62
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 61
Author response 60
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability 59
Anti-Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors 57
The coming of age of liquid biopsy in neuro-oncology 56
Facing contrast-enhancing gliomas: Perfusion MRI in grade III and grade IV gliomas according to tumor area 55
Glioblastomas 52
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 50
Stroke-like events after brain radiotherapy: a large series with long-term follow-up 48
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies 47
Neurological paraneoplastic syndromes: An update 47
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature 47
Isolated seizures are a common early feature of paraneoplastic anti-GABA B receptor encephalitis 46
Herpes simplex encephalitis in glioma patients: A challenging diagnosis 46
IDH-wildtype lower-grade diffuse gliomas: The importance of histological grade and molecular assessment for prognostic stratification 46
Late-onset vascular complications of radiotherapy for primary brain tumors: a case–control and cross-sectional analysis 45
In vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective Study 44
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors 44
Motor neuron disease of paraneoplastic origin: a rare but treatable condition 44
Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma 43
Advanced neuroimaging studies: a patient-centered revolution 43
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes 43
Targeting glioblastoma stem-cells: A recurrent challenge in neuro-oncology 43
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 43
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies 43
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci 43
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas 43
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies 42
Initial clinical presentation of young children with N-methyl-D-aspartate receptor encephalitis 42
Episodic Memory Impairments in Primary Brain Tumor Patients 41
Viral infections of the nervous system 41
Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine 41
Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review 41
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 39
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 39
Paraneoplastic cerebellar degeneration associated with Anti-ITPR1 antibodies 39
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors 39
Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor? 38
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy 38
Neurological syndromes associated with anti-gad antibodies 38
The clinical use of IDH1 and IDH2 mutations in gliomas 38
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 37
Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity 37
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 37
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 37
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 37
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma 37
Meningeal melanomatosis: a challenge for timely diagnosis 36
MINCR: A long non-coding RNA shared between cancer and neurodegeneration 36
Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretation 35
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies 34
Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice 34
Hypersomnia in anti-glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study 32
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 32
The molecular landscape of glioma in patients with Neurofibromatosis 1 31
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults 28
Totale 3.698
Categoria #
all - tutte 27.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 1 0 0 0 0
2021/202282 0 0 0 0 10 1 63 2 1 2 0 3
2022/2023401 139 87 19 4 4 56 19 20 29 1 5 18
2023/2024359 6 26 31 19 16 153 24 26 2 4 5 47
2024/20251.180 127 16 25 49 152 107 193 101 150 72 76 112
2025/20261.674 211 310 298 511 260 84 0 0 0 0 0 0
Totale 3.698